Air Pollution Not Linked to Amyotrophic Lateral Sclerosis Risk

Environmental Triggers and Motor Neuron Degeneration

The etiology of amyotrophic lateral sclerosis remains largely idiopathic, though a complex interplay between genetic susceptibility and environmental triggers is widely suspected [1, 2]. While research has established clear links between ambient air pollution and various cardiovascular and respiratory morbidities, its role in neurodegeneration is a subject of ongoing clinical debate [3, 4]. Some epidemiological data suggest that particulate matter and gaseous pollutants may cross biological barriers to induce neuroinflammation or the aggregation of TAR DNA-binding protein 43 (a pathological protein marker found in nearly all amyotrophic lateral sclerosis cases), potentially accelerating the onset of motor neuron disease [5, 6]. However, existing evidence remains inconsistent. For instance, a nested case-control study of 256 deaths found non-significant associations for fine particulate matter (PM2.5), with odds ratios for mortality often hovering near 1.0 [7]. Given the rising global burden of neurodegenerative disorders, clarifying whether ubiquitous environmental exposures represent modifiable risk factors is a high priority for clinical prevention strategies [8, 2]. A prospective analysis of 501,308 UK Biobank participants now provides a definitive look at this association by evaluating long-term exposure to nitrogen dioxide and particulate matter [9].

Cohort Characteristics and Exposure Assessment

To investigate whether chronic air pollution exposure drives motor neuron degeneration, researchers conducted a prospective cohort study utilizing the UK Biobank. The study population consisted of 501,308 participants who were between the ages of 40 and 69 years at the time of enrollment. At the start of the observation period, the cohort had a mean age of 56.5 years (standard deviation 8.1), and 272,764 individuals (54.4%) were female. To ensure the validity of the incidence data, the analytical sample was restricted to participants who were free of amyotrophic lateral sclerosis at baseline and for whom complete air pollution exposure data were available. The investigation focused on exposure levels recorded over a 15-year period from 2006 to 2021. The primary pollutants studied included nitrogen dioxide (NO2) and nitrogen oxides (NOX), alongside particulate matter of varying aerodynamic diameters. These included fine particulate matter (PM2.5), which refers to inhalable particles with diameters of 2.5 micrometers or smaller, and coarse particulate matter (PM10), which includes particles with diameters less than 10 micrometers. These pollutants are of high clinical interest due to their ability to penetrate deep into the lung tissue and, in the case of fine particles, potentially cross the alveolar-capillary barrier to enter the systemic circulation. Environmental data were sourced from the UK Department for Environment, Food and Rural Affairs. To achieve high precision in exposure modeling, the researchers utilized a spatial resolution of 1 by 1 kilometer, allowing for a granular assessment of the atmospheric conditions surrounding each participant's residence. This high-resolution approach provided a robust framework for evaluating whether chronic inhalation of these specific pollutants correlates with the neurodegenerative processes that lead to amyotrophic lateral sclerosis in a large, aging population.

Longitudinal Analysis of ALS Incidence

The researchers tracked the cohort over a median follow-up of 8.4 years, during which time 687 individuals developed amyotrophic lateral sclerosis. To evaluate the relationship between environmental exposures and disease onset, the study utilized multivariable time-varying Cox proportional hazards models. This statistical technique accounts for changes in pollutant exposure levels over the course of the study period to more accurately predict the risk of a clinical event. By adjusting for these temporal variations, the authors sought to identify whether cumulative or fluctuating exposure to atmospheric toxins influenced the neurodegenerative process. The analysis demonstrated that no associations were observed for any of the examined pollutants and amyotrophic lateral sclerosis risk. When calculating the risk per standard deviation increment, the hazard ratio for coarse particulate matter (PM10) was 1.03 (95% CI 0.92-1.15), while the hazard ratio for fine particulate matter (PM2.5) was 1.00 (95% CI 0.88-1.14). Similarly, nitrogen-based pollutants showed no correlation with the disease, yielding a hazard ratio of 1.01 (95% CI 0.90-1.13) for nitrogen oxides (NOX) and a hazard ratio of 1.00 (95% CI 0.89-1.12) for nitrogen dioxide (NO2). For practicing neurologists and primary care physicians, these findings suggest that, within the exposure levels present in the United Kingdom during the study period, ambient air pollution does not significantly contribute to the incidence of this fatal motor neuron disease.

Linearity and Genetic Interactions

To ensure that the lack of association was not masking a non-linear dose-response relationship, the researchers employed restricted cubic spline analyses (a statistical method used to model complex, non-linear relationships between variables). These analyses revealed no nonlinear associations between air pollution and amyotrophic lateral sclerosis risk, with all p-values for nonlinearity exceeding 0.05. Furthermore, when the cohort was divided into thirds based on their level of exposure, individuals in the highest tertile of air pollutant exposure did not show a higher risk of amyotrophic lateral sclerosis compared with those in the lowest tertile, a finding supported by a p-value for trend greater than 0.05. These results remained robust across various subgroup and sensitivity analyses, confirming that the lack of correlation was consistent regardless of how the data were partitioned or adjusted. The study also investigated whether specific genetic predispositions might make certain individuals more vulnerable to the neurotoxic effects of air pollution. The researchers examined gene-environment interactions stratified by C9orf72 status and UNC13A genotype, which are two of the most common genetic mutations associated with motor neuron disease susceptibility. Despite this targeted approach, no evidence of gene-environment interaction was found regarding C9orf72 or UNC13A. Based on these comprehensive data, the study concluded that ambient air pollution was not a risk factor for the development of amyotrophic lateral sclerosis in this large population-based cohort. For the practicing clinician, these findings provide high-level reassurance that current levels of atmospheric pollutants, including particulate matter and nitrogen oxides, are unlikely to be primary drivers of amyotrophic lateral sclerosis, allowing physicians to focus preventive and diagnostic discussions on more established genetic and clinical risk factors.

References

1. Chalitsios CV, Rudolf O, Gao J, Turner MR, Thompson AG. Long-Term Exposure to Ambient Air Pollution and Incident Amyotrophic Lateral Sclerosis. Neurology. 2026. doi:10.1212/wnl.0000000000214858

2. Kulcsárová K, Piel JHA, Schaeffer E. Environmental toxins in neurodegeneration - a narrative review. Neurological Research and Practice. 2025. doi:10.1186/s42466-025-00452-6

3. Khreis H, Bredell C, Fung KW, et al. Impact of long-term air pollution exposure on incidence of neurodegenerative diseases: A protocol for a systematic review and exposure-response meta-analysis. Environment International. 2022. doi:10.1016/j.envint.2022.107596

4. Peters S, Bouma F, Hoek G, Janssen N, Vermeulen R. Air pollution exposure and mortality from neurodegenerative diseases in the Netherlands: A population-based cohort study. Environmental Research. 2024. doi:10.1016/j.envres.2024.119552

5. Calderón‐Garcidueñas L, Stommel EW, Torres‐Jardón R, et al. Alzheimer and Parkinson diseases, frontotemporal lobar degeneration and amyotrophic lateral sclerosis overlapping neuropathology start in the first two decades of life in pollution exposed urbanites and brain ultrafine particulate matter and industrial nanoparticles, including Fe, Ti, Al, V, Ni, Hg, Co, Cu, Zn, Ag, Pt, Ce, La, Pr and W are key players. Metropolitan Mexico City health crisis is in progress. Frontiers in Human Neuroscience. 2024. doi:10.3389/fnhum.2023.1297467

6. Calderón‐Garcidueñas L, Torres‐Jardón R, Greenough G, et al. Sleep matters: Neurodegeneration spectrum heterogeneity, combustion and friction ultrafine particles, industrial nanoparticle pollution, and sleep disorders—Denial is not an option. Frontiers in Neurology. 2023. doi:10.3389/fneur.2023.1117695

7. Malek AM, Arena V, Song R, et al. Long-term air pollution and risk of amyotrophic lateral sclerosis mortality in the Women's Health Initiative cohort.. Environmental Research. 2022. doi:10.2139/ssrn.4102818

8. Killin L, Starr JM, Shiue I, Russ TC. Environmental risk factors for dementia: a systematic review. BMC Geriatrics. 2016. doi:10.1186/s12877-016-0342-y

9. Chalitsios CV, Rudolf O, Gao J, Turner MR, Thompson AG. Long-Term Exposure to Ambient Air Pollution and Incident Amyotrophic Lateral Sclerosis: A Prospective Cohort Analysis of the UK Biobank.. Neurology. 2026. doi:10.1212/WNL.0000000000214858